-
Jiangsu Hengrui Pharmaceuticals Secures NMPA Approvals for SHR-2106 and HRS-1893 Clinical Trials
•
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has separately announced receiving clinical trial approvals from the National Medical Products Administration (NMPA) for its two drug candidates, SHR-2106 and HRS-1893. SHR-2106: A Pioneering Monoclonal Antibody for Organ TransplantationSHR-2106 is an in-house developed monoclonal antibody (mAb) with no similar product approved…
-
Galvanize Therapeutics Partners with Energenx Medical for Greater China Expansion
•
US-based Galvanize Therapeutics Inc. has revealed a licensing deal with Shanghai-based Energenx Medical Ltd, which will see Energenx develop and commercialize Galvanize’s products in Greater China, including Hong Kong, Taiwan, and Macau. Financial details of the agreement have not been disclosed. Energenx was established by Galvanize in collaboration with founding…
-
AstraZeneca Launches Calquence in China for Mantle Cell Lymphoma Treatment
•
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) has announced the official market launch of Calquence (acalabrutinib), a second-generation Bruton’s tyrosine kinase (BTK) inhibitor, in China. The drug previously received conditional marketing approval in the country in March this year, specifically for the treatment of mantle cell lymphoma (MCL) that has…
-
Kangtai Biological Partners with Indian Pharmaceutical Giant for 13-Valent Pneumonia Vaccine
•
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601), a leading Chinese biopharmaceutical company, has entered into a partnership with a top-tier Indian pharmaceutical company. The collaboration aims to facilitate the regulatory filing, marketing, and distribution of Kangtai Bio’s dual carrier 13-valent pneumonia vaccine in India. Indian Pharmaceutical Company’s Extensive ReachThe…
-
Medtronic Launches AiBLE Orthopedic Ecosystem and Partners with Allinmd Orthopedics in China
•
US-based Medtronic Inc., (NYSE: MDT) has launched AiBLE, an innovative ecological ecosystem concept for orthopedics, in the Chinese market. This collaborative platform aims to connect industry, academia, research, and medicine, leveraging existing orthopedic integration platforms, industry chain capabilities, digitalization, and artificial intelligence technologies. With an open and collaborative approach, Medtronic…
-
TYK Medicines Partners with WuXi STA for Comprehensive CMC Services
•
Shanghai-based TYK Medicines has announced a partnership with WuXi STA, a subsidiary of WuXi AppTec (SHA: 603259), to enhance their collaboration in the field of Chemistry, Manufacturing, and Controls Development (CMC) services. According to the agreement, WuXi STA will serve as a strategic partner to TYK Medicines, offering one-stop services…
-
Beijing’s E-Health Now Secures Tens of Millions in Series B Financing
•
E-Health Now, a comprehensive health management platform headquartered in Beijing, has reportedly raised tens of millions of renminbi in a Series B financing round. The round was led by Orient State-Owned Capital, with additional investments from Ventech China, GSR Ventures, LangRun Investment, and Tongji Fund. E-Health Now’s AI-Powered Digital Healthcare…
-
Boyi Biotech Secures Over RMB100 Million in Series A Financing Led by JOLMO
•
Boyi Biotech, a prominent biological microspheres developer headquartered in Changzhou, has reportedly secured more than RMB100 million in a Series A financing round. The round was led by JOLMO, with additional investments from Bondshine Capital, Wei Chi Equity Fund, and Hua Guoping, the founder of Jiangsu Hualan New Pharmaceutical Material…
